News

Dow Jones futures edged higher after hours, while S&P 500 futures and Nasdaq futures rose modestly. Nvidia earnings topped views late, with shares rising, along with AI peers Broadcom, Taiwan ...
Nutanix reported fiscal third-quarter earnings that topped consensus estimates while July quarter revenue guidance edged by views.
Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...
Scientists have discovered a range of "biomarkers" that could help to improve detection and treatment of gastrointestinal ...
An estimated 5.17% of patients with inflammatory bowel diseases also have bronchiectasis, as shown in chest CT scans of patients with IBD.
Scientists have discovered a range of 'biomarkers' that could help to improve detection and treatment of gastrointestinal ...
Enthera Pharmaceuticals ("Enthera"), a clinical-stage biotech company developing a first-in-class antibody therapeutic targeting the Insulin Growth Factor Binding Protein 3 (IGFBP3)/TMEM219 pathway ...